American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

AtaiBeckley Inc. (ATAI)

$7.35 +0.82% NASDAQ: ATAI · 15-min delayed

NEW YORK, New York
Public · NASDAQ: ATAI
99 employees

Visit website Follow

$2.7BMarket cap

$4.1MRevenue · FY2025

-$660.0MNet income

99Employees

ATAINASDAQ

2021IPO

About AtaiBeckley Inc.

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: ATAI
Employees: 99
IPO date: Jun 18, 2021
Headquarters: C/O ATAI LIFE SCIENCES US, INC.
NEW YORK, New York 10119
Phone: 1 929 207 2670
Industry: Pharmaceuticals
Website: Visit site

Incorporation record

Incorporated in: DE, United States
Registered office: Wilmington, US
Legal entity ID: 529900HOVZ0MXOBQ5Y47

Source: GLEIF, the global Legal Entity Identifier registry · checked Jul 26, 2026. A US headquarters does not always mean US incorporation.

Registry IDs

Ticker: ATAI Nasdaq
SEC CIK: 2081043
LEI: 529900HOVZ0MXOBQ5Y47
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show AtaiBeckley Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/ataibeckley-inc/"><img src="https://americancompanies.com/badge/ataibeckley-inc.svg" alt="AtaiBeckley Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow AtaiBeckley Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $4.1M
Net income: -$660.0M
Total assets: $292.7M
Market cap: $2.7B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: ATAI

$7.35 +0.82%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$3.35 $7.44

52-week range

Market cap: $2.7B
Shares outstanding: 361.4M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Jun 18, 2021

AtaiBeckley Inc. (ATAI) Stock Price

Reported a net loss of $660.0M in FY2025.
Trading near its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review AtaiBeckley Inc..

Write a review

Newsroom

News about AtaiBeckley Inc.

Why Eli Lilly Stock Climbed Today The Motley Fool · 2026-08-05 · positive Why AtaiBeckley Stock Soared Today The Motley Fool · 2026-07-16 · positive AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder GlobeNewswire Inc. · 2026-07-06 · positive AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026 GlobeNewswire Inc. · 2026-05-27 · positive AtaiBeckley Announces Additional Phase 2a Results for EMP-01 (oral R-MDMA) Showing Large and Consistent Improvements in Social Anxiety Disorder GlobeNewswire Inc. · 2026-04-22 · positive AtaiBeckley to Participate in Upcoming Needham Healthcare Conferences GlobeNewswire Inc. · 2026-04-14 · positive

News & sentiment via Polygon.io

FAQ

AtaiBeckley Inc.: frequently asked questions

Is AtaiBeckley Inc. an American company?

AtaiBeckley Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is AtaiBeckley Inc. headquartered?

AtaiBeckley Inc. is headquartered in New York, New York, United States.

Is AtaiBeckley Inc. publicly traded?

Yes — AtaiBeckley Inc. is a publicly traded company. Its stock trades under the ticker symbol ATAI on the NASDAQ.

What does AtaiBeckley Inc. do?

AtaiBeckley Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore